BIO-FLASH Hits 1,000 Installations Worldwide

Autoimmunity has hit a major milestone with 1,000 BIO-FLASH chemiluminescent analyzers placed in laboratories around the world.

A scalable random-access solution for routine and specialized Autoimmunity testing, BIO-FLASH technology has significantly reduced the need to send out tests and has improved response times for both regular and urgent requests.

More accurate and faster Autoimmune diagnosis leads to more effective treatment, significantly improving numerous patients' lives. With its robust chemiluminescent technology, BIO-FLASH provides flexible test processing and improved turnaround time in the lab. Its broad QUANTA Flash menu of autoantibody testing offers precise quantification and a wide analytical range, ensuring precise and reliable results. To date, the 1,000 BIO-FLASHs have processed over 87 million QUANTA Flash tests worldwide.

Congratulations to all those contributing to the success of BIO-FLASH — from R&D, Manufacturing, Finance, Marketing, Sales and Service, Supply Chain, Quality, Regulatory — leading to the achievement of 1,000 installations. Reaching this milestone is a testament to our teams’ dedication and focus on making a difference in the lives of Autoimmune patients around the world.

 

EEMEA Marketing Team

Last modified on Tuesday, 24 February 2026 11:37

 

All rights reserved. © werfen.com

Get in touch

with the EEMEA team:

eemea@werfen.com

 

werfenplain

Issues

Go to top